mrc

No matter what stage your research is at, your target maybe suitable for our small molecule drug discovery programme or our therapeutic antibody programmes.

Why we need your targets

With pharma pulling out of early stage drug discovery research and many universities unable to support drug discovery in-house, MRC Technology established the Centre for Therapeutics Discovery, which is also funded by the UK's Medical Research Council, to offeran academic resource for quality drug discovery capability

How you benefit by collaborating with us:

• Potential access to funding
• We offer provision of tool compounds
  and reagents/ability to raise
  antibodies against your target
  for further validation and
  characterisation studies
• In silico screening and compound design
• Access to medicinal chemistry, screening technologies and ADMET
• Any income generated from programmes shared with your organisation